Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience

Dario Cattaneo; Tiziana Formenti; Antonio Gidaro; Andrea Merlo; Cristina Gervasoni

doi:10.1055/s-0040-1718398

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2020; 46(08): 999-1001
DOI: 10.1055/s-0040-1718398

Letter to the Editor

Use of Direct Oral Anticoagulants in People Living with HIV: A Single-Center Experience

Dario Cattaneo

¹Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

²Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

,

Tiziana Formenti

³Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

,

Antonio Gidaro

⁴Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy

,

Andrea Merlo

⁴Department of Biomedical and Clinical Sciences Luigi Sacco, University of Milan, Luigi Sacco Hospital Milan, Milan, Italy

,

Cristina Gervasoni

¹Gestione Ambulatoriale Politerapie (GAP) Outpatient Clinic, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

³Department of Infectious Diseases, ASST Fatebenefratelli Sacco University Hospital, Milan, Italy

References
1 Lutsey PL, Walker RF, MacLehose RF, Alonso A, Adam TJ, Zakai NA. Direct oral anticoagulants and warfarin for venous thromboembolism treatment: trends from 2012 to 2017. Res Pract Thromb Haemost 2019; 3 (04) 668-673
2 Lippi G, Gosselin R, Favaloro EJ. Current and emerging direct oral anticoagulants: state-of-the-art. Semin Thromb Hemost 2019; 45 (05) 490-501
3 Lippi G, Mattiuzzi C, Cervellin G, Favaloro EJ. Direct oral anticoagulants: analysis of worldwide use and popularity using Google trends. Ann Transl Med 2017; 5 (16) 322
4 West TA, Perram J, Holloway CJ. Use of direct oral anticoagulants for treatment of atrial fibrillation in patients with HIV: a review. Curr Opin HIV AIDS 2017; 12 (06) 554-560
5 Cattaneo D, Cossu MV, Rizzardini G. Pharmacokinetic drug evaluation of ritonavir (versus cobicistat) as adjunctive therapy in the treatment of HIV. Expert Opin Drug Metab Toxicol 2019; 15 (11) 927-935
6 Pastori D, Mezzaroma I, Pignatelli P, Violi F, Lip GYH. Atrial fibrillation and human immunodeficiency virus type-1 infection: a systematic review. Implications for anticoagulant and antiarrhythmic therapy. Br J Clin Pharmacol 2019; 85 (03) 508-515
7 Jackson BS, Pretorius E. Pathological clotting and deep vein thrombosis in patients with HIV. Semin Thromb Hemost 2019; 45 (02) 132-140
8 Steffel J, Verhamme P, Potpara TS. et al; ESC Scientific Document Group. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 2018; 39 (16) 1330-1393
9 Tseng AL, Luetkehoelter J, Walmsley SL. Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin: boosters are not always equal. AIDS 2017; 31 (01) 175-176
10 Good BL, Gomes DC, Fulco PP. An unexpected interaction between warfarin and cobicistat-boosted elvitegravir. AIDS 2015; 29 (08) 985-986
11 Esterly JS, Darin KM, Gerzenshtein L, Othman F, Postelnick MJ, Scarsi KK. Clinical implications of antiretroviral drug interactions with warfarin: a case-control study. J Antimicrob Chemother 2013; 68 (06) 1360-1363
12 Liedtke MD, Vanguri A, Rathbun RC. A probable interaction between warfarin and the antiretroviral TRIO study regimen. Ann Pharmacother 2012; 46 (11) e34
13 Welzen ME, van den Berk GE, Hamers RL, Burger DM. Interaction between antiretroviral drugs and acenocoumarol. Antivir Ther 2011; 16 (02) 249-252
14 Liedtke MD, Rathbun RC. Drug interactions with antiretrovirals and warfarin. Expert Opin Drug Saf 2010; 9 (02) 215-223
15 Aspromonte N, Colivicchi F. Clinical relevance of pharmacokinetic and pharmacodynamic properties of edoxaban when treating patients with atrial fibrillation and heart failure. Expert Opin Drug Metab Toxicol 2017; 13 (01) 113-122
16 Serrao A, Santoro C, Foà R, Chistolini A. Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients. HIV Med 2020; 21 (03) e7